• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James B. Grogan, PhD

AMA Arch Surg. 1969;99(3):382-384.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

TRANSPLANTATION of kidneys and other organs have become a common procedure in many medical centers. The use of immunosuppressants has made this possible, but it is clear that immunosuppression can create a serious defect in host resistance which often results in death of the transplant recipient because of infection.¹ One of the newest and now widely used immunosuppressants is antilymphocyte serum (ALS). Though its exact mode of action is unknown, it is a powerful suppressant of the cellular response. Recent reports have shown ALS to act as an anti-inflammatory agent in response to certain chemicals^2,3 and bacterial antigens.⁴ A definite increased susceptibility to a number of virus infections has been reported in animals treated with ALS leading to an increased morbidity and mortality.⁵ Little is known about the effect of ALS on host resistance to infections of bacterial origin. This report deals with this subject and . . . [Full Text PDF of this Article]

Author Affiliations

From the Department of Surgery, University of Mississippi Medical Center, Jackson.

Footnotes

Reprint requests to Department of Surgery, University of Mississippi Medical Center, 2500 N State St, Jackson, Miss 39216 (Dr. Grogan).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?